Literature DB >> 9601074

Direct observation of lipoprotein cholesterol ester degradation in lysosomes.

S Lusa1, K Tanhuanpää, T Ezra, P Somerharju.   

Abstract

We have investigated whether pyrene-labelled cholesterol esters (PyrnCEs) (n indicates the number of aliphatic carbons in the pyrene-chain) can be used to observe the degradation of low-density lipoprotein (LDL)-derived cholesterol esters (CEs) in the lysosomes of living cells. To select the optimal substrates, hydrolysis of the PyrnCE species by lysosomal acid lipase (LAL) in detergent/phospholipid micelles was compared. The rate of hydrolysis varied markedly depending on the length of the pyrenyl chain. Pyr10CE was clearly the best substrate, while Pyr4CE was practically unhydrolysed. Pyr10CE and [3H]cholesteryl linoleate, the major CE species in LDL, were hydrolysed equally by LAL when incorporated together into reconstituted LDL (rLDL) particles, thus indicating that Pyr10CE is a reliable reporter of the lysosomal degradation of native CEs. When rLDL particles containing Pyr4CE or Pyr10CE were incubated with fibroblasts, the accumulation of bright intracellular vesicular fluorescence was observed with the former fluorescent derivative, but not with the latter. However, when the cells were treated with chloroquine, an inhibitor of lysosomal hydrolysis, or when cells with defective LAL were employed, Pyr10CE also accumulated in vesicular structures. HPLC analysis of cellular lipid extracts fully supported these imaging results. It is concluded that PyrnCEs can be used to observe degradation of CEs directly in living cells. This should be particularly useful when exploring the mechanisms responsible for the accumulation of lipoprotein-derived CEs in complex systems such as the arterial intima.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9601074      PMCID: PMC1219500          DOI: 10.1042/bj3320451

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  49 in total

1.  Membrane penetration depth and lipid phase preference of acyl-labeled dansyl phosphatidylcholines in phosphatidylcholine vesicles.

Authors:  D Bartlett; M Glaser; R Welti
Journal:  Biochim Biophys Acta       Date:  1997-08-14

2.  Deficiency of an acid lipase in Wolman's disease.

Authors:  A D Patrick; B D Lake
Journal:  Nature       Date:  1969-06-14       Impact factor: 49.962

3.  Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339.

Authors:  J L Goldstein; G Y Brunschede; M S Brown
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

4.  Role of lysosomal acid lipase in the metabolism of plasma low density lipoprotein. Observations in cultured fibroblasts from a patient with cholesteryl ester storage disease.

Authors:  J L Goldstein; S E Dana; J R Faust; A L Beaudet; M S Brown
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

5.  Transversal distribution of acyl-linked pyrene moieties in liquid-crystalline phosphatidylcholine bilayers. A fluorescence quenching study.

Authors:  M Sassaroli; M Ruonala; J Virtanen; M Vauhkonen; P Somerharju
Journal:  Biochemistry       Date:  1995-07-11       Impact factor: 3.162

6.  Degradation of pyrene-labelled phospholipids by lysosomal phospholipases in vitro. Dependence of degradation on the length and position of the labelled and unlabelled acyl chains.

Authors:  S Lusa; M Myllärniemi; K Volmonen; M Vauhkonen; P Somerharju
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

7.  The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.

Authors:  S Lusa; M Jauhiainen; J Metso; P Somerharju; C Ehnholm
Journal:  Biochem J       Date:  1996-01-01       Impact factor: 3.857

8.  Metabolism and distribution of intramolecular excimer-forming dipyrenebutanoyl glycerophospholipids in human fibroblasts. Marked resistance to metabolic degradation.

Authors:  J Kasurinen; P Somerharju
Journal:  Biochemistry       Date:  1995-02-14       Impact factor: 3.162

9.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

10.  Visualization of the transport pathways of low density lipoproteins across the endothelial cells in the branched regions of rat arteries.

Authors:  C H Kao; J K Chen; J S Kuo; V C Yang
Journal:  Atherosclerosis       Date:  1995-07       Impact factor: 5.162

View more
  2 in total

1.  Specific cellular incorporation of a pyrene-labelled cholesterol: lipoprotein-mediated delivery toward ordered intracellular membranes.

Authors:  Gérald Gaibelet; Sophie Allart; François Tercé; Vincent Azalbert; Justine Bertrand-Michel; Safouane Hamdi; Xavier Collet; Stéphane Orlowski
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

Review 2.  Fluorescent Sterols and Cholesteryl Esters as Probes for Intracellular Cholesterol Transport.

Authors:  Katarzyna A Solanko; Maciej Modzel; Lukasz M Solanko; Daniel Wüstner
Journal:  Lipid Insights       Date:  2016-06-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.